doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: leukemia

1 - 5 of 21 <<previous | next>>

Drugs results:

Sildenafil pill

Sildenafil

Sildenafil under the name Viagra is used to treat erectile dysfunction (impotence) in men. Another brand of sildenafil is Revatio, which is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women. It relaxes muscles an more...

Natalizumab

Natalizumab

Natalizumab is in a class of drug known as monoclonal antibody. This medicine affects the actions of the body's immune system. Natalizumab is used in to treat relapsing forms of multiple sclerosis, a demyelinating neurologic disease. more...

Diseases results:

Erectile dysfunction
Multiple sclerosis
Blood disorder
Anemia
Cancer
Itching
Stop smoking

Articles results:

Case Western Reserve University Licenses Methoxyamine To Tracon: New Therapy Reverses Resistance To Chemotherapy
Case Western Reserve University's Technology Transfer Office has entered a worldwide exclusive licensing agreement with TRACON Pharmaceuticals of San Diego, Calif., to develop Methoxyamine, a new cancer therapeutic that reverses cancer cell resistance to chemotherapy. Methoxyamine is a "first in class" drug that targets a specific DNA repair pathway.


Callisto Pharmaceuticals Announces Publication Of Research Articles On Atiprimod Preclinical Studies In Myeloid And Other Malignancies
Callisto Pharmaceuticals, Inc.


Novartis Highlights Strong R&D Pipeline, Plans For Multiple New Product Launches And Novel Projects Moving Into Late-stage Trials
Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.


Indian Health Minister Urges Novartis To Withdraw Case Against Country's Drug Patents Act
Over concern that the global supply of low-cost antiretroviral drugs could be disrupted, Indian Health Minister Anbumani Ramadoss on Tuesday urged pharmaceutical company Novartis to withdraw its challenge to a section of India's Patents Act that aims to restrict certain kinds of patents,


Novartis Will Wait Until Indian Court Issues Decision In Patents Act Challenge Before Deciding How To Proceed
Swiss pharmaceutical company Novartis recently said it will wait until an Indian court rules on the company's challenge to a section of the country's Patents Act that aims to restrict certain kinds of patents before deciding how to proceed, Dow Jones reports (Parussini, Dow Jones, 5/14).




1 - 5 of 21 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.